Inventor

GEISEN KARL

DE34 patents

⚠️ This page may combine multiple inventors who share the name “GEISEN KARL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GEISEN KARL

HOECHST AG

Heterocyclic substituted sulfonyl ureas, and their use

Piperazine substituted pyrimidine derivatives and physiologically tolerated salts thereof

Benzoic acids, their derivatives and process for preparing them

Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them

Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them

Antidiabetic 1-piperidine-sulfonylureas

Certain nicotinamido-n-benzoic acid derivatives

Substituted pyrimidine derivatives, a process for the preparation thereof and the use thereof as reagents

4-Quinazolinyl-guanidines

Thienopyrrolone substituted benezenesulfonylureas and their use

Benzenesulfonyl ureas and their use for the treatment of diabetes mellitus

Antidiabetic salicylic acid derivatives

Amorphous monospheric forms of insulin derivatives

Benzenesulfonyl ureas, and pharmaceutical preparations

Sulfonyl ureas and pharmaceutical preparations thereof

Benzenesulfonyl ureas

Oxirane pseudooligosaccharides, a process for their preparation, their use and pharmaceutical preparations

Pseudooligosaccharides with an α-glucosidase-inhibiting action, their use and pharmaceutical products

Substituted quinoxalyl-imidazolidine-2,4-diones, processes for their preparation, their use as medicaments and pharmaceutical preparations

AVENTIS PHARMA GMBH

Insulin derivatives having a rapid onset of action

Use of polycyclic 2-aminothiazole systems for the treatment of obesity

Polycyclic 2- aminothiazole systems, processes for their preparation and pharmaceuticals comprising these compounds

Insulin derivatives with increased zinc binding

Insulin analogs with enhanced zinc binding

Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures

Polycyclic thiazole systems, processes for their preparation and pharmaceuticals comprising these compounds

Polycyclic thiazolidin-2-ylidene amines, process for their preparation, and their use as pharmaceuticals

Polycyclic 2-aminodihydrothiazole systems, processes for their preparation and their use as pharmaceuticals

Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals

Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments

Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments

Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments

AVENTISPHARMA DEUTSCHLAND GMBH

Use of polycyclic thiazole systems for the treatment of obesity

AVENTIS PHARMA DEUTSCHAND GMBH

Polycyclic dihydrothiazoles, their preparation, and use as pharmaceuticals